Manufacturer record
Stallion Laboratories Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Stallion Laboratories Pvt. Ltd (Gujarat) were declared Not of Standard Quality between May 2020 and June 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: T3180, Glipizide Tablets I.P. 5 mg (exp Feb 2025). CDL Kolkata (CDSCO lab) found it not of standard quality: Dissolution. Listed in the June 2023 alert.
Records by type
4 records linked to Stallion Laboratories Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Glipizide Tablets I.P. 5 mg | Batch T3180Mfg Mar 2023 · Exp Feb 2025 | DissolutionDissolution | CDL KolkataCDSCO lab | Jun 2023 |
| Budecort Respules 0.5 mg (Budesonide Nebuliser Suspension B.P.) | Batch IA20131Mfg Feb 2022 · Exp Jan 2024 | AssayAssay | CDL KolkataCDSCO lab | Jan 2023 |
| Albendazole Tablets IP 400 mg | Batch T3037Mfg Aug 2022 · Exp Jul 2024 | DissolutionDissolution | CDL KolkataCDSCO lab | Nov 2022 |
| Onstal - 4 (Ondansetron Tablets IP 4 mg) | Batch T2227Mfg Aug 2018 · Exp Jul 2020 | DescriptionDescription | CDL KolkataCDSCO lab | May 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.